K133464 is an FDA 510(k) clearance for the MODIFIED TREVO PROVUE RETRIEVER. Classified as Catheter, Thrombus Retriever (product code NRY), Class II - Special Controls.
Submitted by Concentric Medical, Inc. (Mountain View, US). The FDA issued a Cleared decision on January 17, 2014 after a review of 66 days - a notably fast clearance cycle.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.
View all Concentric Medical, Inc. devices
NCT01270867
Completed
Interventional
Industry-sponsored
Randomized Trial Evaluating Performance of the Trevo Retriever Versus the Merci Retriever in Acute Ischemic Stroke
Thrombectomy REvascularization of Large Vessel Occlusions in Acute Ischemic Stroke (TREVO 2)
| Condition studied |
Ischemic Stroke |
| Study design |
Parallel |
| Eligibility |
All sexes
· 18 Years+
|
| Principal investigator |
Raul G Nogueira, MD |
| Sponsor |
Stryker Neurovascular
(industry)
|
Started 2011-02-01
→
Primary completion 2011-12-01
→
Completed 2012-03-01
Primary outcome
Primary Efficacy Endpoint
Secondary outcome
Secondary Endpoint
View full study on ClinicalTrials.gov